Alex Haahr Gouliaev
Directeur Général chez Atz Holding ApS
Profil
Alex Haahr Gouliaev was the founder of Nuevolution AB, founded in 2001, where he held the title of Chief Executive Officer.
Currently, he is the Chief Executive Officer at Nuevolution A since 2004 and also holds the same title at Atz Holding ApS.
His former job was at NTG Nordic Transport Group A, where he held the position of Director & Director-Chemistry Department from 1996 to 2001.
Dr. Gouliaev received his doctorate degree from the University of Aarhus in 1996 and his graduate degree from the University of Southern Denmark in 1994.
Postes actifs de Alex Haahr Gouliaev
Sociétés | Poste | Début |
---|---|---|
Atz Holding ApS | Directeur Général | - |
Nuevolution A/S
Nuevolution A/S Miscellaneous Commercial ServicesCommercial Services Nuevolution A/S engages in research and experimental development on biotechnology. It produces and commercializes technologies for the manufacture of substances for use in the pharmaceutical industry by screening non-biological polymers and low-molecular substances. The company was founded on May 8, 2001 and is headquartered in Copenhagen, Denmark. | Directeur Général | 30/09/2004 |
Anciens postes connus de Alex Haahr Gouliaev
Sociétés | Poste | Fin |
---|---|---|
NTG NORDIC TRANSPORT GROUP A/S | Directeur/Membre du Conseil | 01/01/2001 |
NUEVOLUTION AB (PUBL) | Directeur Général | - |
Formation de Alex Haahr Gouliaev
University of Aarhus | Doctorate Degree |
University of Southern Denmark | Graduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
NTG NORDIC TRANSPORT GROUP A/S | Transportation |
Entreprise privées | 3 |
---|---|
Nuevolution AB
Nuevolution AB Pharmaceuticals: MajorHealth Technology Nuevolution AB engages in pharmaceutical and biotechnology discovery. Its activities include research and development, and licensing drugs and treatment of oncology and chronic inflammatory diseases including cancer. It offers the platform Chemetics, which enables discovery of small molecule drug candidates for specific indications addressing target diseases. The company was founded by Henrik Pedersen, Alex Haahr Gouliaev, and Mads Nørregaard-Madsen in May 2001 and is headquartered in Copenhagen, Denmark. | Health Technology |
Atz Holding ApS | |
Nuevolution A/S
Nuevolution A/S Miscellaneous Commercial ServicesCommercial Services Nuevolution A/S engages in research and experimental development on biotechnology. It produces and commercializes technologies for the manufacture of substances for use in the pharmaceutical industry by screening non-biological polymers and low-molecular substances. The company was founded on May 8, 2001 and is headquartered in Copenhagen, Denmark. | Commercial Services |